Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Buccoliero, F.
98  Ergebnisse:
Personensuche X
?
1

Antagonistic signalling by PPARgamma and rosiglitazone conv..:

Mello, T. ; Tarocchi, M. ; Perini, F....
Digestive and Liver Disease.  46 (2014)  - p. e38 , 2014
Link: https://doi.org/10.1016/..
 
?
2

P.01.4 ADAM-9 EXPRESSION MEDIATES COUP-TFII-DEPENDENT INVAS..:

Ceni, E. ; Mello, T. ; Tarocchi, M....
Digestive and Liver Disease.  46 (2014)  - p. S53-S54 , 2014
Link: https://doi.org/10.1016/..
 
?
3

PC.02.2 TARGET THERAPY: A TELOMERASE ACTIVATED THYMIDINE AN..:

Tarocchi, M. ; Polvani, S. ; Peired, A....
Digestive and Liver Disease.  45 (2013)  - p. S56-S57 , 2013
Link: https://doi.org/10.1016/..
 
?
4

P.10.21 COUP-TFII DOWNREGULATION INHIBITS PANCREATIC CANCER..:

Polvani, S. ; Tarocchi, M. ; Tempesti, S....
Digestive and Liver Disease.  45 (2013)  - p. S164-S165 , 2013
Link: https://doi.org/10.1016/..
 
?
5

COUP-TFII downregulation inhibits pancreatic cancer growth:

Polvani, S. ; Tarocchi, M. ; Buccoliero, F....
Pancreatology.  12 (2012)  6 - p. 546-547 , 2012
Link: https://doi.org/10.1016/..
 
?
6

313 TELOMERASE ACTIVATED THYMIDINE ANALOGUE PROD-DRUG PREVE..:

Tarocchi, M. ; Polvani, S. ; Calamante, M....
Journal of Hepatology.  56 (2012)  - p. S128 , 2012
Link: https://doi.org/10.1016/..
 
?
7

P.03.2 KEY REGULATION OF SIRT1 IN THE PRO-SURVIVAL AND ACTI..:

Tarocchi, M. ; Vellei, S. ; Buccoliero, F....
Digestive and Liver Disease.  44 (2012)  - p. S99-S100 , 2012
Link: https://doi.org/10.1016/..
 
?
8

OC.05.3 ROSIGLITAZONE REDUCES THE IN VITRO AND IN VIVO ONCO..:

Mello, T. ; Tarocchi, M. ; Buccoliero, F....
Digestive and Liver Disease.  44 (2012)  - p. S66-S67 , 2012
Link: https://doi.org/10.1016/..
 
?
9

T-33 Knockdown of Ruvbl-1 reduces HCC cells growth in vitro..:

Mello, T. ; Tarocchi, M. ; Buccoliero, F....
Digestive and Liver Disease.  44 (2012)  - p. S25 , 2012
Link: https://doi.org/10.1016/..
 
?
10

400 IMPORTANT ROLE OF SIRT1 IN THE SURVIVAL AND ACTIVATION ..:

Tarocchi, M. ; Vellei, S. ; Buccoliero, F....
Journal of Hepatology.  56 (2012)  - p. S160 , 2012
Link: https://doi.org/10.1016/..
 
?
11

T-32 In vivo and in vitro models support the therapeutic ef..:

Tarocchi, M. ; Polvani, S. ; Ceni, E....
Digestive and Liver Disease.  44 (2012)  - p. S25 , 2012
Link: https://doi.org/10.1016/..
 
?
12

P.1.133: PONTIN52 IS A PPARGAMMA TARGET GENE AND ITS KNOCKD..:

Mello, T. ; Tarocchi, M. ; Buccoliero, F....
Digestive and Liver Disease.  43 (2011)  - p. S192 , 2011
Link: https://doi.org/10.1016/..
 
?
13

P.1.142: TELOMERASE ACTIVATED THYMIDINE ANALOGUE PRO-DRUG I..:

Tarocchi, M. ; Polvani, S. ; Mello, T....
Digestive and Liver Disease.  43 (2011)  - p. S195 , 2011
Link: https://doi.org/10.1016/..
 
?
14

P.153 PES-003, A NEW PRO-DRUG FOR PANCREATIC CANCER THERAPY:

Polvani, S. ; Calamante, M. ; Ottanelli, B....
Digestive and Liver Disease.  42 (2010)  - p. S157 , 2010
Link: https://doi.org/10.1016/..
 
?
15

T.N.23 ROSIGLITAZONE INHIBITS HEPATOCELLULAR CANCER CELL GR..:

Mello, T. ; Buccoliero, F. ; Tarocchi, M....
Digestive and Liver Disease.  42 (2010)  - p. S23 , 2010
Link: https://doi.org/10.1016/..
 
1-15